Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+4.6%
5Y CAGR+12.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+4.6%/yr
vs +14.9%/yr prior
5Y CAGR
+12.5%/yr
Recent deceleration
Acceleration
-10.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$14.42M+6.8%
2024$13.50M-3.8%
2023$14.04M+11.4%
2022$12.61M+11.5%
2021$11.31M+41.4%
2020$8.00M-24.7%
2019$10.62M+47.0%
2018$7.22M+48.7%
2017$4.86M-25.0%
2016$6.48M-